Outlook Therapeutics- Warrants's total assets is $22T.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), OTLKW shows a total assets of $22T. That compares with $19T in the prior-year period — up 14.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, OTLKW's total assets is now $22T (was $19T) — a 14.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Outlook Therapeutics- Warrants is outperforming or lagging.
Tracking OTLKW's total assets over time shows whether Outlook Therapeutics- Warrants is scaling, shrinking, or reshaping that part of the business. The current reading is $22T That compares with $19T in the prior-year period — up 14.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total assets page, Stockcircle has Outlook Therapeutics- Warrants's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $22T) with ownership activity and broader fundamentals.
Outlook Therapeutics- Warrants's total assets is $22T; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.